COVID-19 infection after minimally invasive esophagectomy: Two cases report_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

LI Changding ^1,2 , LI Jialong ¹ , XIAO Wenguang ¹ , XU Shanling ¹ ,  HAN Yongtao ¹ ,  LENG Xuefeng ¹

1. Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 640041, P. R. China;
2. Graduate School of Southwest Medical University, Luzhou, 464000, Sichaun, P. R. China;
3. Department of Critical Care Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 640041, P. R. China;

Corresponding author：

HAN Yongtao, Email: hanyongt@uestc.edu.cn; LENG Xuefeng, Email: doc.leng@uestc.edu.cn

Keywords：

Esophageal cancer; COVID-19; esophagectomy; case report

DOI：

10.7507/1007-4848.202301038

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Two male patients (75 years and 51 years, respectively) suffered infection of novel coronavirus after minimally invasive surgery for esophageal squamous cell carcinoma in Sichuan Cancer Hospital since December 2022. Both patients developed severe hypoxemia after surgery, and were treated with advanced oxygen therapy, antiviral therapy, hormone shock therapy, antibiotic anti-infection and nutritional support. The two patients stayed in the intensive care unit for 6 days and 8 days respectively. They were transferred to the general ward for symptomatic treatment and were discharged successfully. Both patients required low-flow oxygen maintenance after discharge. On the 20th day of follow-up after discharge, patient 1 still needed low-flow oxygen, his oxygen saturation could be maintained above 97%, but intermittent deoxygenation could be performed for half an hour. Patient 2 was in good condition on 35 days after discharge.

Citation： LI Changding, LI Jialong, XIAO Wenguang, XU Shanling, HAN Yongtao, LENG Xuefeng. COVID-19 infection after minimally invasive esophagectomy: Two cases report. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(7): 962-966. doi: 10.7507/1007-4848.202301038 Copy

1.	Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. Lancet, 2020, 395(10241): 1907-1918.
2.	Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol, 2020, 21(3): 335-337.
3.	中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析. 中华流行病学杂志, 2020, 41(2): 145-151.
4.	Pinato DJ, Aguilar-Company J, Ferrante D, et al. Outcomes of the SARS-CoV-2 omicron (B. 1. 1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: Results from the retrospective, multicentre, OnCovid registry study. Lancet Oncol, 2022, 23(7): 865-875.
5.	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
6.	季刚, 卫江鹏, 卢强. 2022年V3版《NCCN食管和食管胃结合部癌临床实践指南》更新解读. 中国胸心血管外科临床杂志, 2022, 29(11): 1414-1423.
7.	李勇, 秦建军, 王镇, 等. 新型冠状病毒肺炎疫情下食管癌患者外科诊治对策. 中华肿瘤杂志, 2020, 42(4): 296-300.
8.	李辉, 游宾, 区颂雷, 等. 新冠疫情期间胸外科手术风险管控的几点建议. 中国胸心血管外科临床杂志, 2023, 30(2): 159-161.
9.	简辉, 吴安定, 王娟娟, 等. 新型冠状病毒肺炎合并消化道出血8例报告. 山东医药, 2020, 60(17): 46-48.
10.	Mei H, Luo L, Hu Y. Thrombocytopenia and thrombosis in hospitalized patients with COVID-19. J Hematol Oncol, 2020, 13(1): 161.
11.	Le Balc'h P, Pinceaux K, Pronier C, et al. Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients. Crit Care, 2020, 24(1): 530.
12.	Borgstein ABJ, Brunner S, Hayami M, et al. Safety of esophageal cancer surgery during the first wave of the COVID-19 pandemic in europe: A multicenter study. Ann Surg Oncol, 2021, 28(9): 4805-4813.
13.	Wang Q, Yao C, Li Y, et al. The safety of esophageal cancer surgery during COVID-19. Medicine (Baltimore), 2022, 101(41): e30929.
14.	Bajaj SS, Shah KM, Potter AL, et al. Early vs delayed surgery for esophageal cancer during the COVID-19 pandemic. J Am Coll Surg, 2022, 235(2): 174-184.
15.	中国抗癌协会肿瘤支持治疗专业委员会, 中国抗癌协会肿瘤临床化疗专业委员会. 新型冠状病毒肺炎疫情期间实体肿瘤患者防护和诊治管理相关问题中国专家共识(2022版). 中华肿瘤杂志, 2022, 44(10): 1083-1090.
16.	Barbieri L, Talavera Urquijo E, Parise P, et al. Esophageal oncologic surgery in SARS-CoV-2 (COVID-19) emergency. Dis Esophagus, 2020, 33(5): doaa028.
17.	Mahase E. Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ, 2021, 375: n2713.

1. Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. Lancet, 2020, 395(10241): 1907-1918.
2. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol, 2020, 21(3): 335-337.
3. 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析. 中华流行病学杂志, 2020, 41(2): 145-151.
4. Pinato DJ, Aguilar-Company J, Ferrante D, et al. Outcomes of the SARS-CoV-2 omicron (B. 1. 1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: Results from the retrospective, multicentre, OnCovid registry study. Lancet Oncol, 2022, 23(7): 865-875.
5. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
6. 季刚, 卫江鹏, 卢强. 2022年V3版《NCCN食管和食管胃结合部癌临床实践指南》更新解读. 中国胸心血管外科临床杂志, 2022, 29(11): 1414-1423.
7. 李勇, 秦建军, 王镇, 等. 新型冠状病毒肺炎疫情下食管癌患者外科诊治对策. 中华肿瘤杂志, 2020, 42(4): 296-300.
8. 李辉, 游宾, 区颂雷, 等. 新冠疫情期间胸外科手术风险管控的几点建议. 中国胸心血管外科临床杂志, 2023, 30(2): 159-161.
9. 简辉, 吴安定, 王娟娟, 等. 新型冠状病毒肺炎合并消化道出血8例报告. 山东医药, 2020, 60(17): 46-48.
10. Mei H, Luo L, Hu Y. Thrombocytopenia and thrombosis in hospitalized patients with COVID-19. J Hematol Oncol, 2020, 13(1): 161.
11. Le Balc'h P, Pinceaux K, Pronier C, et al. Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients. Crit Care, 2020, 24(1): 530.
12. Borgstein ABJ, Brunner S, Hayami M, et al. Safety of esophageal cancer surgery during the first wave of the COVID-19 pandemic in europe: A multicenter study. Ann Surg Oncol, 2021, 28(9): 4805-4813.
13. Wang Q, Yao C, Li Y, et al. The safety of esophageal cancer surgery during COVID-19. Medicine (Baltimore), 2022, 101(41): e30929.
14. Bajaj SS, Shah KM, Potter AL, et al. Early vs delayed surgery for esophageal cancer during the COVID-19 pandemic. J Am Coll Surg, 2022, 235(2): 174-184.
15. 中国抗癌协会肿瘤支持治疗专业委员会, 中国抗癌协会肿瘤临床化疗专业委员会. 新型冠状病毒肺炎疫情期间实体肿瘤患者防护和诊治管理相关问题中国专家共识(2022版). 中华肿瘤杂志, 2022, 44(10): 1083-1090.
16. Barbieri L, Talavera Urquijo E, Parise P, et al. Esophageal oncologic surgery in SARS-CoV-2 (COVID-19) emergency. Dis Esophagus, 2020, 33(5): doaa028.
17. Mahase E. Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ, 2021, 375: n2713.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

COVID-19 infection after minimally invasive esophagectomy: Two cases report

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content